Brand at a glance

  • Globally Recognised Orthopaedic Product Specialist

  • Over 11,000 Available Products & Procedures

  • Comitted to Product Education & Procedure Training

  • Environmetally Sustainable Manufacturing

access the vadi medical product range

Download the brochure and view our trusted range of technologies and systems with clinically proven techniques, materials and products. Fill the form below to receive an email.

Please fill all mandatory fields
Thank you

We will be in touch shortly.

Something went wrong

The brochure could not be sent at this time.

Click to retry

Introducing Device Online

The Device Technologies digital product catalogue and ecommerce ordering website.

Learn more

About SI-Bone

Founded in 2008, SI-BONE primarily focuses on advancing diagnostic understandings of the sacroiliac joint, and minimally invasive surgery for certain causes of SI joint disorders.

The focus on this one specific region of the spine is done with a purpose, as it is one of the most under-served, under-diagnosed, and under-treated areas in orthopaedics.

Read More

SI-BONE, which is run by experienced team of executives from Kyphon, Medtronic, INBONE, Saint Francis and several start-up orthopaedic and spine companies, aims to improve knowledge around the sacroiliac joint, and provide improved solutions to help treat conditions around it.

Read Less



SI-BONE is focused on advancing the understanding of the sacroiliac joint. Not only that, but they also aim to come up with solutions to assist in its treatment and in reducing pain, patient function, and quality of life.

They aim to focus on this through a triangular designed implant, mirroring their goal of being different from their contemporaries. The strength in the product and its design contributes to this vision. SI-BONE provide clinically proven results for their products in published data.


As a provider of solutions for sacroiliac joint fusion, SI-BONE partners with Device Technologies to bring their product to healthcare professionals in the Australian and New Zealand market.